West Pharmaceutical Services (WST) Revenue — Quarter Ended Dec 31, 2024
Revenue increased in the current quarter compared to both the immediately preceding quarter and the same quarter one year earlier. The sequential growth was slight, while the year-over-year gain was more pronounced.
Key takeaway
Quarter ended Dec 31, 2024 · FY2024 Q4
Revenue increased in the current quarter compared to both the immediately preceding quarter and the same quarter one year earlier. The sequential growth was slight, while the year-over-year gain was more pronounced.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$748.8M
Revenue reported for this quarter.
Quarter-over-quarter
+0.3%
Change from the immediately preceding quarter.
Year-over-year
+2.3%
Change from the comparable year-ago quarter.
Trailing four quarters
$2.9B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Mar 31, 2024 | $695.4M | -3.0% |
| Jun 30, 2024 | $702.1M | -6.9% |
| Sep 30, 2024 | $746.9M | -0.1% |
| Dec 31, 2024 | $748.8M | +2.3% |
Revenue performance
Revenue for the quarter rose, marking a continuation of the upward trend observed over the prior two quarters. The increase was modest relative to the preceding quarter.
Quarterly comparison
Compared with the immediately preceding quarter, revenue showed a slight increase. Compared with the same quarter one year ago, the increase was more substantial.
What to watch
The minimal sequential revenue change makes the next quarter's performance a key indicator of whether the growth trend will accelerate or plateau.